US2009221807A1PendingUtilityA1

2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid

Assignee: SIRNA THERAPEUTICS INCPriority: Mar 29, 1994Filed: Sep 8, 2008Published: Sep 3, 2009
Est. expiryMar 29, 2014(expired)· nominal 20-yr term from priority
A61K 48/00C12N 2310/3513C12N 2310/3535C07H 19/04C12N 2310/122C12N 2310/127C12N 2310/32C12N 2310/3533C12N 2310/123C12N 2310/334C12N 15/101C07H 19/048A61K 38/00C12N 15/1131C12N 2310/3527C12N 2310/335C07H 21/04C12N 2310/111C12N 15/113C07H 21/02C12N 2310/336C12N 15/1136C12N 2310/1241C12N 15/1138C12N 2310/3523C12N 2310/121C12N 2310/126C12N 2310/333C12N 2310/322
76
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

2′-deoxy-2′-alkylnucleotides useful for stabilizing enzymatic nucleic acid molecules and antisense molecules.

Claims

exact text as granted — not AI-modified
1 . A 2′-deoxy-2′-C-allyl nucleoside selected from the group consisting of 2′-deoxy-2′-C-allyl-beta-D-ribofuranosyl uridine, 2′-deoxy-2′-C-allyl-beta-D-ribofuranosyl cytidine, 2′-deoxy-2′-C-allyl-beta-D-ribofuranosyl adenosine, and 2′-deoxy-2′-C-allyl-beta-D-ribofuranosyl guanosine. 
     
     
         2 . An oligonucleotide A RNA comprising one or more 2′-C-allyl nucleotide 2′-deoxy-2′-C-allyl nucleotides selected from the group consisting of 2′-deoxy-2′-C-allyl-beta-D-ribofuranosyl uridine, 2′-deoxy-2′-C-allyl-beta-D-ribofuranosyl cytidine, 2′-deoxy-2′-C-allyl-beta-D-ribofuranosyl adenosine, and 2′-deoxy-2′-C-allyl-beta-D-ribofuranosyl guanosine. 
     
     
         3 . The oligonucleotide RNA of  claim 3 , wherein said oligonucleotide RNA is single stranded. 
     
     
         4 . The oligonucleotide RNA of  claim 3 , wherein said oligonucleotide RNA is double stranded.

Join the waitlist — get patent alerts

Track US2009221807A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.